Cymra Life Sciences is an Australian owned licenced importer and manufacturer of medical cannabis. We’ve set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.
We are focused on the development of cannabis medicines for chronic and neuropathic pain.
WHY? We don’t believe there is good long term medication options for chronic pain conditions (i.e opiates) are a good long term medication and have serious side effects.
We’re one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method which delivers a consistent, natural product, free from pests and chemical dependencies.
The team at Cymra Life Sciences is innovative, ambitious and fast-moving, all backed up by years of experience across pain management, medical research, plant genetics and breeding.
Why Tissue Culture?
Our Strategic Pillars
Genetics & Tissue Culture
Scientific & Clinical Research
Condition Based Pharmaceutical Formulations
Partnerships & Distribution
Experienced Board & Advisory Team